- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sansure Biotech Inc (688289)
Sansure Biotech Inc stock price live, this page displays SS 688289 stock exchange data. View the 688289 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sansure Biotech Inc real time stock price chart below.
What Is the Sansure Biotech Inc Stock Price Today?
The Sansure Biotech Inc stock price today is 15.71.
What Is the Stock Symbol for Sansure Biotech Inc?
The stock symbol for Sansure Biotech Inc is "688289."
What Stock Exchange Does Sansure Biotech Inc Trade On?
Sansure Biotech Inc is listed and trades on the Shanghai stock exchange.
Is Sansure Biotech Inc a Good Stock to Buy?
Determining whether Sansure Biotech Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688289 quote. (ISIN: CNE1000043J1)
What Is the Sansure Biotech Inc Stock Price Today?
The Sansure Biotech Inc stock price today is 15.71.
What Is the Stock Symbol for Sansure Biotech Inc?
The stock symbol for Sansure Biotech Inc is "688289."
What Stock Exchange Does Sansure Biotech Inc Trade On?
Sansure Biotech Inc is listed and trades on the Shanghai stock exchange.
Is Sansure Biotech Inc a Good Stock to Buy?
Determining whether Sansure Biotech Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688289 quote. (ISIN: CNE1000043J1)
Shanghai
Currency in CNY
15.71
+0.37(+2.41%)
Closed·
Fair Value
An estimate of a Sansure Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.35
15.89
52 wk Range
13.40
23.45
688289 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Sansure Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.3515.89
52 wk Range
13.4023.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688289 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sansure Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
22.02
Upside
+40.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 22.02
(+40.17% Upside)
Earnings
Latest Release
Apr 30, 2026
EPS / Forecast
-- / --
Revenue / Forecast
437M / --
Compare 688289 to Peers and Sector
Metrics to compare | 688289 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688289PeersSector | |
|---|---|---|---|---|
P/E Ratio | 56.2x | 27.8x | −0.4x | |
PEG Ratio | −1.24 | −0.63 | 0.00 | |
Price/Book | 1.2x | 1.9x | 2.6x | |
Price / LTM Sales | 5.5x | 4.9x | 3.0x | |
Upside (Analyst Target) | 40.5% | 37.1% | 53.2% | |
Fair Value Upside | Unlock | 18.6% | 9.0% | Unlock |
Sansure Biotech Inc. researches and develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. It offers nucleic acid and multiple nucleic acid diagnostic kits for coronavirus, CoV-2, influenza virus, and respiratory syncytial virus; DNA fluorescence and nucleic acid diagnostic kits for respiratory tract infections, HPV infections, and reproductive tract infections; nucleic acid tests and fluorescence diagnostic kits for blood-borne infections; RNA diagnostic kits for gastrointestinal infections; and diagnostic kits for monkeypox, epstein-barr virus, and human cytomegalovirus DNA, as well as rapid antigen tests. The company provides nucleic acid extraction or purification kits, multi-type sample DNA/RNA extraction-purification kits, and sample release reagents; sample storage reagents for SARS-CoV-2; extraction instruments and systems; and PCR instruments comprising real-time quantitative thermal cyclers, portable molecule workstations, and real-time PCR systems. In addition, it engages in the research and development, production, and sale of drugs; procurement and sale of raw materials; manufacture of instruments; manufacture and sale of electronic equipment; trading; investment consulting; medical research and experimental development; and internet sales, as well as offers third-party medical testing and biotechnology development services. The company was founded in 2008 and is headquartered in Changsha, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Sansure Biotech (688289) Stock Price Today?
The Sansure Biotech stock price today is 15.71 CNY.
What Stock Exchange Does Sansure Biotech Trade On?
Sansure Biotech is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Sansure Biotech?
The stock symbol for Sansure Biotech is "688289."
What Is the Sansure Biotech Market Cap?
As of today, Sansure Biotech market cap is 8.82B CNY.
What Is Sansure Biotech's Earnings Per Share (TTM)?
The Sansure Biotech EPS (TTM) is 0.26.
When Is the Next Sansure Biotech Earnings Date?
Sansure Biotech will release its next earnings report on Aug 27, 2026.
From a Technical Analysis Perspective, Is 688289 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sansure Biotech Stock Split?
Sansure Biotech has split 1 times.
How Many Employees Does Sansure Biotech Have?
Sansure Biotech has 2128 employees.
What is the current trading status of Sansure Biotech (688289)?
As of Jul 20, 2026, Sansure Biotech (688289) is trading at a price of 15.71 CNY, with a previous close of 15.34 CNY. The stock has fluctuated within a day range of 15.35 CNY to 15.89 CNY, while its 52-week range spans from 13.40 CNY to 23.45 CNY.
What Is Sansure Biotech (688289) Price Target According to Analysts?
The average 12-month price target for Sansure Biotech is 22.02 CNY, with a high estimate of 22.02 CNY and a low estimate of 22.02 CNY. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +40.17% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.